Investegate |Charm Therapeutics Announcements | Charm Therap

Investegate announcements from Charm Therapeutics, CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology

Related Keywords

London , City Of , United Kingdom , Muz Mansuri , Sergey Bartunov , Chris Bischoff , Sarah Skerratt , David Baker , Nessan Bermingham , Gary Glick , Alex Morgan , Laksh Aithani , Google Deepmind , Garyd Glick , Nihal Sinha , Committee At Sanofi , Vertex Pharmaceuticals , Gilead Sciences , Company Is , Head Of The Institute For Protein Design , Head Of Preclinical Sciences , Pfizer , University Of Washington , Consilium Strategic Communications , F Prime Capital , General Catalyst , Khosla Ventures , Executive Chair , Chief Executive Officer , Board Member , Protein Design , Wiley Prize , Scorpion Therapeutics , Odyssey Therapeutics , Venture Partner , Executive Committee , Orchard Therapeutics , Rishi Gupta , Senior Vice President , Drug Discovery , Preclinical Sciences , Managing Director , Intellia Therapeutics , Chief Executive , Investegate Announcements , Investegate Company Announcements , Charm Therapeutics , Lobenewswire , Lobenewswire And Globenewswire , Nw ,